А. М. Попов

1.7k total citations
176 papers, 901 citations indexed

About

А. М. Попов is a scholar working on Public Health, Environmental and Occupational Health, Hematology and Molecular Biology. According to data from OpenAlex, А. М. Попов has authored 176 papers receiving a total of 901 indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Public Health, Environmental and Occupational Health, 51 papers in Hematology and 49 papers in Molecular Biology. Recurrent topics in А. М. Попов's work include Acute Lymphoblastic Leukemia research (64 papers), Acute Myeloid Leukemia Research (34 papers) and Chronic Myeloid Leukemia Treatments (18 papers). А. М. Попов is often cited by papers focused on Acute Lymphoblastic Leukemia research (64 papers), Acute Myeloid Leukemia Research (34 papers) and Chronic Myeloid Leukemia Treatments (18 papers). А. М. Попов collaborates with scholars based in Russia, Belarus and Bulgaria. А. М. Попов's co-authors include N. Yanishlieva, А. И. Киселев, Grigory Tsaur, Л. Г. Фечина, G. А. Novichkova, Michael Maschan, G. B. Elyakov, Yulia Olshanskaya, E. Ya. Kostetsky and Н. К. Уткина and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

А. М. Попов

155 papers receiving 840 citations

Peers

Countries citing papers authored by А. М. Попов

Since Specialization

Citations

This map shows the geographic impact of А. М. Попов's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by А. М. Попов with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites А. М. Попов more than expected).

Fields of papers citing papers by А. М. Попов

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by А. М. Попов. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by А. М. Попов. The network helps show where А. М. Попов may publish in the future.

Co-authorship network of co-authors of А. М. Попов

This figure shows the co-authorship network connecting the top 25 collaborators of А. М. Попов. A scholar is included among the top collaborators of А. М. Попов based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with А. М. Попов. А. М. Попов is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Transient abnormal myelopoiesis, myelodysplastic syndrome and acute myeloid leukemia in children with Down syndrome 2024 ·Pediatric Hematology/Oncology and Immunopathology ·(unknown), (unknown), (unknown), (unknown), (unknown), Elena Zerkalenkova, (unknown), Yulia Olshanskaya, (unknown), А. М. Попов, K. A. Voronin, Alexey Maschan, G. А. Novichkova	0
2	TP53 variants underlying pediatric low‐hypodiploidy B‐cell acute lymphoblastic leukemia demonstrate diverse origins and may persist as a hematopoietic clone in remission 2024 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), А. М. Попов, Elena Zerkalenkova, (unknown), G. А. Novichkova, (unknown), Yulia Olshanskaya	1
3	Flow cytometry in acute leukemia diagnostics. Guidelines of Russian-Belarusian multicenter group for pediatric leukemia studies 2023 ·Pediatric Hematology/Oncology and Immunopathology ·А. М. Попов, (unknown), (unknown), I. A. Demina, (unknown), (unknown), (unknown), (unknown), (unknown), G. А. Novichkova	9
4	The role of blinatumomab in the treatment of B-cell relapses of acute lymphoblastic leukemia in children: own experience 2023 ·Pediatric Hematology/Oncology and Immunopathology ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Elena Kurnikova, А. М. Попов, Yulia Olshanskaya, Michael Maschan, (unknown), (unknown), А. В. Попа, (unknown)	0
5	Guidelines for the use of flow cell sorting in diagnosis and monitoring of acute leukemia 2023 ·Pediatric Hematology/Oncology and Immunopathology ·(unknown), (unknown), I. A. Demina, (unknown), Elena Zerkalenkova, (unknown), (unknown), (unknown), Michael Maschan, G. А. Novichkova, А. М. Попов	1
6	Guidelines for the flow cytometric minimal residual disease monitoring in B-lineage acute lymphoblastic leukemia after CD19-directed immunotherapy 2023 ·Pediatric Hematology/Oncology and Immunopathology ·(unknown), (unknown), Michael Maschan, G. А. Novichkova, (unknown), А. М. Попов	3
7	Targeted Therapy With Venetoclax and Daratumumab as Part of HSCT Preparative Regimen in Children With Chemorefractory Acute Myeloid Leukemia 2022 ·Transplantation and Cellular Therapy ·(unknown), (unknown), (unknown), (unknown), (unknown), А. М. Попов, (unknown), (unknown), (unknown), (unknown), Dmitry Pershin, Dmitry Balashov, Alexei Maschan, Michael Maschan	6
8	Acute lymphoblastic leukemia in children with Down syndrome: “Moscow–Berlin” experience 2021 ·Pediatric Hematology/Oncology and Immunopathology ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Olga Aleynikova, Л. Г. Фечина, (unknown), (unknown), (unknown), А. М. Попов, Yulia Olshanskaya, (unknown), Alexey Maschan, G. А. Novichkova, (unknown)	1
9	The influence of a dosage regimen of dexamethasone on detection of normal B-cell precursors in the bone marrow of children with BCP-ALL at the end of induction therapy 2020 ·Pediatric Hematology/Oncology and Immunopathology ·(unknown), (unknown), (unknown), (unknown), (unknown), Л. Г. Фечина, (unknown), А. М. Попов	4
10	Immunophenotypic characteristics of early T-cell precursor acute lymphoblastic leukemia 2019 ·Pediatric Hematology/Oncology and Immunopathology ·(unknown), (unknown), (unknown), (unknown), Л. Г. Фечина, (unknown), (unknown), А. М. Попов	3
11	Hhe results of different antibodies application for CD1a expression evaluation in pediatric t-lineage all 2019 ·Pediatric Hematology/Oncology and Immunopathology ·(unknown), (unknown), (unknown), (unknown), А. М. Попов	1
12	Immunophenotypic characterization of acute megakaryoblastic leukaemia in children 2019 ·Pediatric Hematology/Oncology and Immunopathology ·(unknown), (unknown), (unknown), Elena Zerkalenkova, (unknown), (unknown), Л. Г. Фечина, Grigory Tsaur, Yulia Olshanskaya, А. М. Попов	2
13	High‐throughput sequencing of T‐cell receptor alpha chain clonal rearrangements at the DNA level in lymphoid malignancies 2019 ·British Journal of Haematology ·Alexander Komkov, (unknown), (unknown), А. М. Попов, Mikhail V. Pogorelyy, (unknown), (unknown), Šárka Pospı́šilová, Yuri B. Lebedev, Dmitriy M. Chudakov, Yulia Olshanskaya, Karla Plevová, Michael Maschan, Ilgar Z. Mamedov	9
14	Peg-Asparaginase Administration on Day 3 of Remission Induction Accelerates MRD Response in Children with B-Cell Precursor Acute Lymphoblastic Leukemia 2017 ·Blood ·А. М. Попов, (unknown), (unknown), (unknown), (unknown), Elena Boyakova, (unknown), (unknown), (unknown), (unknown), (unknown), Natalia Miakova, (unknown), (unknown), (unknown), Olga Aleinikova, Guenter Henze, (unknown)	0
15	Changes in Leukemic Blasts CD19 Expression in Children with Relapsed/Refractory B-Cell Precursor ALL Treated with Blinatumomab 2017 ·Blood ·(unknown), (unknown), (unknown), (unknown), Alexey Maschan, Natalia Miakova, А. М. Попов	2
16	Immunophenotypic investigation of infant acute myeloid leukemia 2014 ·SHILAP Revista de lepidopterología ·А. М. Попов, Grigory Tsaur, (unknown), (unknown), (unknown), (unknown), (unknown)	0
17	Immunophenotypic investigation of infant acute lymphoblastic leukemia 2014 ·SHILAP Revista de lepidopterología ·А. М. Попов, Grigory Tsaur, (unknown), (unknown), (unknown), (unknown), Л. Г. Фечина	2
18	ROLE OF THE MORPHOMETRIC PARAMETERS OF INTRATUMORAL MICROVESSELS AND THE PROLIFERATIVE ACTIVITY OF TUMOR CELLS IN RENAL CELL CARCINOMA 2014 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), А. М. Попов, (unknown), (unknown), (unknown), (unknown)	1
19	Comparative Study of Effects of Various Sterols and Triterpenoids on Permeability of Model Lipid Membranes 2003 ·Journal of Evolutionary Biochemistry and Physiology ·А. М. Попов	8
20	The Antimetastatic and Immunomodulating Activities of Ginseng Minor Glycosides 2001 ·Doklady Biochemistry and Biophysics ·А. М. Попов, (unknown), N. I. Uvarova, G. B. Elyakov	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact